If you looked at Intuit 's (NASDAQ: INTU) 51% year-to-date drop without any context, it would be easy to assume that the company's fundamentals have deteriorated substantially. Or you might assume that the company's valuation had previously climbed to too lofty a level, and that it had undergone a necessary correction. However, neither of those things is the case. Intuit is still gaining market sh...
If you looked at Intuit 's (NASDAQ: INTU) 51% year-to-date drop without any context, it would be easy to assume that the company's fundamentals have deteriorated substantially. Or you might assume that the company's valuation had previously climbed to too lofty a level, and that it had undergone a necessary correction. However, neither of those things is the case. Intuit is still gaining market share and has high profit margins. And in the wake of its decline, it has an 18.5 price-to-earnings (P/E) ratio . Its valuation hasn't been this low in more than a decade. Image source: Getty Images. Continue reading
New college graduates around the country have been booing and heckling commencement speakers who hype up AI . Microsoft would like everyone to talk it out. In a blog post running more than 3,100 words, Microsoft vice chair and president Brad Smith addressed the recent spate of viral clips from graduation ceremonies, like former Google CEO Eric Schmidt getting an earful at the University of Arizona...
New college graduates around the country have been booing and heckling commencement speakers who hype up AI . Microsoft would like everyone to talk it out. In a blog post running more than 3,100 words, Microsoft vice chair and president Brad Smith addressed the recent spate of viral clips from graduation ceremonies, like former Google CEO Eric Schmidt getting an earful at the University of Arizona , or the speaker in Florida who seemed surprised when students booed at the mention of AI as "the next industrial revolution." The videos speak to a broader societal sentiment around AI - the technology is deeply unpopular even as technology compani … Read the full story at The Verge.
Palantir's 10th AIPCon showcased strong customer adoption of its AIP platform, but PLTR is down roughly 25% in 2026, with technicals weak and earnings in August as the next key catalyst.
Palantir's 10th AIPCon showcased strong customer adoption of its AIP platform, but PLTR is down roughly 25% in 2026, with technicals weak and earnings in August as the next key catalyst.
July ICE NY cocoa (CCN26 ) today is down -77 (-2.01%), and July ICE London cocoa #7 (CAN26 ) is down -49 (-1.67%). Cocoa prices are under pressure today amid forecasts of dry conditions moving into West Africa later this week, which are expected to alleviate flooding concerns. Cocoa prices...
July ICE NY cocoa (CCN26 ) today is down -77 (-2.01%), and July ICE London cocoa #7 (CAN26 ) is down -49 (-1.67%). Cocoa prices are under pressure today amid forecasts of dry conditions moving into West Africa later this week, which are expected to alleviate flooding concerns. Cocoa prices...
July arabica coffee (KCN26 ) today is up +4.55 (+1.86%), and July ICE robusta coffee (RMN26 ) is up +60 (+1.82%). Coffee prices are sharply higher today as short covering emerged after the Japan Meteorological Agency confirmed an El Niño weather pattern had formed across the equatorial Pacific, setting the...
July arabica coffee (KCN26 ) today is up +4.55 (+1.86%), and July ICE robusta coffee (RMN26 ) is up +60 (+1.82%). Coffee prices are sharply higher today as short covering emerged after the Japan Meteorological Agency confirmed an El Niño weather pattern had formed across the equatorial Pacific, setting the...
alexskopje/iStock via Getty Images Investment Overview: Why Roche & Pfizer Are Pinning Hopes On Obesity / Type 2 Diabetes Assets This week, the Pharma giants Roche Holding AG ( RHHBY ) and Pfizer Inc. ( PFE ) both gave presentations at the American Diabetes Association ("ADA") to discuss latest results and outline paths to approval for their respective GLP-1 receptor agonist obesity / Type 2 Diabe...
alexskopje/iStock via Getty Images Investment Overview: Why Roche & Pfizer Are Pinning Hopes On Obesity / Type 2 Diabetes Assets This week, the Pharma giants Roche Holding AG ( RHHBY ) and Pfizer Inc. ( PFE ) both gave presentations at the American Diabetes Association ("ADA") to discuss latest results and outline paths to approval for their respective GLP-1 receptor agonist obesity / Type 2 Diabetes ("T2D") assets - enicepatide and petrelintide in the case of Roche, and berobenatide and met-233i in the case of Pfizer. As readers will likely be aware, the glucagon like peptide-1 ("GLP-1") drug class, exemplified by Eli Lilly's ( LLY ) tirzepatide, approved to treat obesity and Type 2 Diabetes ("T2D"), brand names Zepbound / Mounjaro, and Novo Nordisk's ( NVO ) semaglutide, approved in the same indications as Wegovy / Mounjaro, has become the biggest selling drug class globally. Semaglutide and tirzepatide combined revenues were ~$65bn in 2025. In Q1 2026, semaglutide combined revenues were ~$7bn, and tirzepatide ~$13bn. Top Pharma companies revenues / income compared (my table using Seeking Alpha data) In the table above, I have highlighted 5-year revenue and income performance for 12 of the world's largest Pharmas globally to illustrate the impact that the burgeoning GLP-1 RA market has had on Eli Lilly and Novo Nordisk's ( NVO ) performance. As we can see, on a three-year basis, Eli Lilly's share price has performed better than any other Pharma - up 158%, while its revenue CAGR between 2020 and 2025 is ~22%, also the best, and its net income CAGR is also the best - 27% - excepting Gilead Sciences ( GILD ), whose reported income in 2020 was just $89m, which we can term an anomalous result. Likewise, Novo Nordisk has the second best revenue CAGR of 18%, and the second best net income CAGR - also 18% - Novo stock also climbed by ~300% between 2021 - mid-2024, before operational difficulties created a difficult bear market for shares. Meanwhile, Roche's five-year reve...
It’s easy to look at a stock chart after a big run and feel like you missed the party. ORCL surged more than thirty-eight percent in three months, a significant move for a company of its size. More interesting than the rally itself was the trail of breadcrumbs the company left beforehand.
It’s easy to look at a stock chart after a big run and feel like you missed the party. ORCL surged more than thirty-eight percent in three months, a significant move for a company of its size. More interesting than the rally itself was the trail of breadcrumbs the company left beforehand.
We caught up with listeners before the Odd Lots live recording at City Winery to hear their favorite episodes, most unexpected takeaways and dream guest picks. The answers covered everything from logging in Canada to behavioral economics—and a few very ambitious guest requests. (Source: Bloomberg)
We caught up with listeners before the Odd Lots live recording at City Winery to hear their favorite episodes, most unexpected takeaways and dream guest picks. The answers covered everything from logging in Canada to behavioral economics—and a few very ambitious guest requests. (Source: Bloomberg)
Vanguard Global ex-U.S. Real Estate ETF (NASDAQ:VNQI) offers low-cost, broad international diversification, while iShares Select U.S. REIT ETF (NYSEMKT:ICF) provides concentrated exposure to dominant domestic real estate investment trusts (REITs). Investing in real estate offers a path to diversification and income, but the geography of those assets matters. The iShares ETF focuses on the heavywei...
Vanguard Global ex-U.S. Real Estate ETF (NASDAQ:VNQI) offers low-cost, broad international diversification, while iShares Select U.S. REIT ETF (NYSEMKT:ICF) provides concentrated exposure to dominant domestic real estate investment trusts (REITs). Investing in real estate offers a path to diversification and income, but the geography of those assets matters. The iShares ETF focuses on the heavyweights of the American market, while the Vanguard fund looks abroad to more than 30 different countries. This analysis compares these two strategies to see how concentration, international exposure, and cost impact investors. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading
Nela Richardson, Chief Economist at ADP and a Bloomberg contributor, says employers need to decide whether AI is going to be a tool for automating roles away or augmenting tasks to create new value. She discusses the new Canaries Dashboard, launched by ADP and the Stanford Digital Economy Lab, to provide real-time indications of how AI is reshaping different occupations based on labor market data....
Nela Richardson, Chief Economist at ADP and a Bloomberg contributor, says employers need to decide whether AI is going to be a tool for automating roles away or augmenting tasks to create new value. She discusses the new Canaries Dashboard, launched by ADP and the Stanford Digital Economy Lab, to provide real-time indications of how AI is reshaping different occupations based on labor market data. Richardson joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech.” (Source: Bloomberg)
RiverNorthPhotography/iStock Unreleased via Getty Images Fifth Third Bancorp ( FITB ) has gained access to Anthropic's ( ANTHRO ) cybersecurity initiative, known as Project Glasswing. Earlier this month, Anthropic said it was expanding its cybersecurity initiative to another 150 new organizations. "We were invited into Project Glasswing over the last several weeks," said FITB CFO Bryan Preston at ...
RiverNorthPhotography/iStock Unreleased via Getty Images Fifth Third Bancorp ( FITB ) has gained access to Anthropic's ( ANTHRO ) cybersecurity initiative, known as Project Glasswing. Earlier this month, Anthropic said it was expanding its cybersecurity initiative to another 150 new organizations. "We were invited into Project Glasswing over the last several weeks," said FITB CFO Bryan Preston at the Morgan Stanley U.S. Financials Conference 2026. "We think it was a reflection of just the role we play in the payments ecosystem in the country today, whether it's the Direct Express business, some of the processing that we do for U.S. customs as well as just the magnitude of payroll processing that we do for the country," said Preston. More on Fifth Third Bancorp, Anthropic Fifth Third Bancorp (FITB) Presents at Morgan Stanley US Financials Conference 2026 Transcript Fifth Third Bancorp (FITB) Presents at Morgan Stanley US Financials Conference 2026 - Slideshow Wall Street Lunch: Hot Labor Market Defies Predictions Of AI-Led Job Losses OpenAI prepares tender offer of $687 per share; Altman expects to go public within year: report OpenAI IPO signals floodgates are 'officially open,' Wedbush says
Citi’s Panic/Euphoria Model is off the charts. Wall Street hasn’t felt this good in five years. And investors are taking chances, willing to get burned.
Citi’s Panic/Euphoria Model is off the charts. Wall Street hasn’t felt this good in five years. And investors are taking chances, willing to get burned.
The iShares U.S. Medical Devices ETF (IHI) could be setting up for a turnaround — and a few stock charts detailed here will show why. First, the bad news: IHI has been in a downtrend since the very start of 2026, visibly underperforming the major indices by a wide margin. Along the way, we've seen several rally attempts strong enough to generate moving average convergence/divergence, or MACD, buy ...
The iShares U.S. Medical Devices ETF (IHI) could be setting up for a turnaround — and a few stock charts detailed here will show why. First, the bad news: IHI has been in a downtrend since the very start of 2026, visibly underperforming the major indices by a wide margin. Along the way, we've seen several rally attempts strong enough to generate moving average convergence/divergence, or MACD, buy signals three separate times since the middle of February. As is clear, the prior two signals in February and April both failed at key downtrend lines. The most recent buy signal initially appeared to suffer the same fate in mid-May, but the ensuing pullback produced a marginal higher low and buyers returned as June began. Currently, IHI is trying to leverage that latest MACD buy signal better, as it once again tests the downtrend line connecting the January and early March highs. The question is whether this time is any different. The answer is that yes, it could be. IHI's current bounce has helped build a potential double-bottom formation, with the 51 resistance-level lining up closely with the 50-day moving average, which IHI is now testing for the first time since early 2026. The 14-day relative strength index has also just poked above the 50 level for the first time since late February. Again, we've seen promising rallies before, only to watch them turn into head fakes. Because of that, investors are perhaps doubting this attempt as well. But as just described, this setup has some compelling short-term technicals in its favor this time that it was lacking before. Zooming all the way out to the monthly log chart, it's clear that IHI has also fallen back to a major support zone in the mid-40s. This is the same area where the ETF pulled back to and bounced from on three prior occasions — twice in 2022 and again in 2023. That last test, of course, ultimately led to a multi-year advance that carried IHI back toward its all-time highs. The most recent six-month decline now h...
As AI giants Anthropic and OpenAI prepare for IPOs, the companies are stressing their efforts to ensure the tech is safe and beneficial for humanity. But Safiya Noble, a UCLA professor and director of the university’s Center on Resilience & Digital Justice, says current AI is not safe, and that stereotypes and biases are being built into training data. Noble joins Caroline Hyde and Ed Ludlow on “B...
As AI giants Anthropic and OpenAI prepare for IPOs, the companies are stressing their efforts to ensure the tech is safe and beneficial for humanity. But Safiya Noble, a UCLA professor and director of the university’s Center on Resilience & Digital Justice, says current AI is not safe, and that stereotypes and biases are being built into training data. Noble joins Caroline Hyde and Ed Ludlow on “Bloomberg Tech." (Source: Bloomberg)
美国5月CPI再度升温，同比增速创三年来新高，华尔街的结论却出奇一致：这份报告既没有彻底改变美联储的政策路径，也没有给市场提供明确方向。 有“新美联储通讯社”之称的记者 Nick Timiraos评论称，对于美联储而言，“5月通胀报告什么问题都没有解决”。虽然核心通胀数据低于预期，但能源冲击、AI驱动的需求扩张以及依然强劲的经济增长，使通胀前景仍充满不确定性。 与此同时，多家华尔街机构认为，本次C...
Growing Number Of Oil Tankers Successfully Sneak Through Hormuz, Shrinking Iran's Leverage One week ago we reported that " As Gulf States Plan Bypass Pipelines, US Military Is Quietly Helping Ships Cross Hormuz ." We now have more evidence that, whether with or without a US escort, a growing number of ships are transiting Hormuz. According to Bloomberg, off the coast of Oman over the weekend, 16 t...
Growing Number Of Oil Tankers Successfully Sneak Through Hormuz, Shrinking Iran's Leverage One week ago we reported that " As Gulf States Plan Bypass Pipelines, US Military Is Quietly Helping Ships Cross Hormuz ." We now have more evidence that, whether with or without a US escort, a growing number of ships are transiting Hormuz. According to Bloomberg, off the coast of Oman over the weekend, 16 tankers clustered together to transfer millions of barrels of oil that had been stranded in the Persian Gulf. A month ago, that area had been entirely empty. They’re part of a growing number of tankers that are turning their transponders off to lift oil flows through the Strait of Hormuz from a trickle to a stream. While conventional vessel-tracking data show little change in shipments, senior shipping executives, Asian oil buyers and satellite images paint a different picture: That Hormuz is now a lot less blocked, with transits becoming more steady and greater in volume. As we reported last week, the increase in Gulf producers’ ships going dark to sneak through undetected by Iran is at the heart of the rise in flows, coinciding with a period where the US has been helping ships navigate through the waterway. The recent volumes add to signs that the oil market is managing to route enough to buyers and avert a price surge as the Iran war causes the biggest supply disruption in oil market history. Commenting on the growing number of stealthy ship transits, earlier today Goldman's Delta One head, Rich Privorotsky, said that "a lot has been thrown at the oil market and it’s simply not going up, which is remarkable given the level of escalation. The only conclusion that really fits the price action is that barrels are still getting through the Strait of Hormuz, visibly or otherwise. There doesn’t seem to be a more rational explanation. " Middle East producers have been using vessels they control to ferry barrels outside of Hormuz - avoiding the stratospheric fees that would be co...